Chemoinformaics analysis of Deacetylveralosine
Molecular Weight | 617.824 | nRot | 6 |
Heavy Atom Molecular Weight | 562.384 | nRig | 33 |
Exact Molecular Weight | 617.393 | nRing | 6 |
Solubility: LogS | -4.45 | nHRing | 2 |
Solubility: LogP | 4.068 | No. of Aliphatic Rings | 6 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 0 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 55 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 35 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
nHA | 9 | APOL | 102.64 |
nHD | 4 | BPOL | 62.3924 |
QED | 0.261 |
Synth | 5.509 |
Natural Product Likeliness | 2.682 |
NR-PPAR-gamma | 0.021 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.965 |
Pgp-sub | 0.25 |
HIA | 0.025 |
CACO-2 | -5.141 |
MDCK | 0.0000335 |
BBB | 0.007 |
PPB | 0.953749 |
VDSS | 1.575 |
FU | 0.0235442 |
CYP1A2-inh | 0.007 |
CYP1A2-sub | 0.113 |
CYP2c19-inh | 0.011 |
CYP2c19-sub | 0.662 |
CYP2c9-inh | 0.055 |
CYP2c9-sub | 0.074 |
CYP2d6-inh | 0.018 |
CYP2d6-sub | 0.089 |
CYP3a4-inh | 0.661 |
CYP3a4-sub | 0.304 |
CL | 1.468 |
T12 | 0.231 |
hERG | 0.204 |
Ames | 0.056 |
ROA | 0.401 |
SkinSen | 0.096 |
Carcinogencity | 0.393 |
EI | 0.01 |
Respiratory | 0.972 |
NR-Aromatase | 0.26 |
Antiviral | Yes |
Prediction | 0.599132 |